Similar fatty acid status of plasma lipids in postmenopausal women newly diagnosed with breast cancer and those receiving aromatase inhibitor therapy
Background/Aim. Dysregulation of fatty acid (FA) metabolism is recognized as a component of malignant trans-formation in many cancers, including breast cancer (BC), and is often related to disease progression and prognosis. Adjuvant endocrine BC therapy using aromatase inhibitors may also influence...
Guardado en:
Autores principales: | Krstić Predrag, Vučić Vesna, Paunović Marija, Petrović Snjezana, Nedović Nikola, Kostić Sanja, Arsić Aleksandra |
---|---|
Formato: | article |
Lenguaje: | EN SR |
Publicado: |
Military Health Department, Ministry of Defance, Serbia
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/deeb5ff497e44caf8ed544c52e65bbf1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Aromatase inhibitors, efficacy and metabolic risk in the treatment of postmenopausal women with early breast cancer
por: Stefano Gonnelli, et al.
Publicado: (2008) -
Effect of aromatase inhibitors on sex differentiation and embryonic development in chicks
por: Salwan M. Abdulateef, et al.
Publicado: (2021) -
Cost-effectiveness of Tamoxifen, Aromatase Inhibitor, and Switch Therapy (Adjuvant Endocrine Therapy) for Breast Cancer in Hormone Receptor Positive Postmenopausal Women in India
por: Butani D, et al.
Publicado: (2021) -
Interactions of aromatase and seladin-1: A neurosteroidogenic and gender perspective
por: Kelicen-Ugur Pelin, et al.
Publicado: (2019) -
Hyperprolactinemia in the postmenopause: versions and contraversions
por: Olga Ya. Leshchenko
Publicado: (2021)